Ron Menezes , , , President and Chief Executive Officer

View bioHide bio

Ron Menezes joined Sientra in November 2020 as President and Chief Executive Officer. Ron’s most recent experience includes serving as President and General Manager for Almirall U.S. – Dermatology, where he led exceptional growth and profitability improvements, returning the U.S. division to profitability. Ron was also part of the team that successfully acquired Allergan’s dermatology assets in 2018. In 2019, he led the launch of a new molecule for the treatment of acne that far exceeded revenue goals by strategically focusing on improving patients’ access to the product. Prior to Almirall, Ron was the Vice President of Sales and Marketing for Dermatology at Allergan, leading the team to more than 20% yearly growth between 2013 and 2015. The growth was driven by increased direct-to-consumer advertising and expanding the promotion of a 20-year-old topical product for acne. As a head of sales for SkinMedica, Latisse and Medical Dermatology, Ron was part of the commercial team that successfully launched a new direct-to-physician sunscreen product. While at SkinMedica, he focused on expanding national accounts that were responsible for driving most of the growth in 2015. Ron has also held key leadership responsibilities at Abbott, Astellas Pharma – U.S., Pfizer and Eli Lilly. Ron holds a B.S. in International Business from Brigham Young University and earned a certificate in Health Care Management from the University of Utah.

Oliver Bennett , , , General Counsel and Chief Compliance Officer

View bioHide bio

Oliver Bennett joined Sientra in 2015, first as outside counsel and then as general counsel to the company, prior to becoming General Counsel and Vice President for Compliance and Legal in 2018. Oliver brings with him almost two decades of experience in counseling medical device and life science companies in complex and high stakes legal issues. Prior to joining Sientra, he practiced law at a number of premier firms where he was at the cutting edge of legal practice representing clients in ground-breaking cases that have helped shape US law. Most recently, Oliver was a partner at Kirkland & Ellis LLP. Before that, he was Of Counsel at Kaye Scholer LLP (now Arnold White Kaye Scholer LLP), and an associate at Latham & Watkins, LLP and Clifford Chance US LLP. Oliver received a Master in Laws degree from Harvard Law School where he was also a Fulbright Scholar, and Bachelor of Laws and Bachelor of Arts degrees from Griffith University in Brisbane, Australia.

Denise Dajles , , Dr. , , Senior Vice President R&D, Regulatory and Quality

View bioHide bio

Dr. Denise Dajles joined Sientra in June 2021 as Vice President of Research and Development. Most recently, Denise served as Senior Director of Research, Development and Innovation leading the science and technology department at Establishment Labs. In this role, she was responsible for the successful execution of more than ten new product and technology projects, which includes several regulatory approvals for commercialization in the United States, Europe, Latin America and Asia Pacific, as well as for leading extensive scientific research. Previously, Denise was an advisor, investigator, and Interim Director in the Biomedical Engineering Lab at the University of Costa Rica School of Engineering. Denise holds both a Bachelor of Science and Master of Science in Biomedical Engineering from Washington University, St. Louis and a Doctorate in Engineering from The George Washington University, Washington, DC. She has co-authored several peer reviewed publications and is a named inventor on a number of technologies.

Matt Hostetler , , , Chief People Officer

View bioHide bio

Matt Hostetlerjoined Sientra in April 2022. He brings over 20 years of global Human Resources leadership in biotech and consumer products. Matt is known for designing and implementing sustainable HR strategies in complex environments that positively impact business performance. Prior to joining Sientra, Matt was the head of HR for Kite Pharma, A Gilead Company. Earlier in his career, Matt held multiple leadership roles at Amgen and Honeywell. He earned both his Master of Labor and Human Resources and his Bachelor of Science in Business from The Ohio State University.

Jeff Jones , , , Vice President, Operations

View bioHide bio

Jeff Jones joined Sientra in 2019. He brings over 30 years of operations and quality experience with both medical device start-ups and Fortune 500 companies to Sientra. Most recently, Jeff was Vice President of Quality and Commercial Operations at Earlens, a medical device startup that makes direct-drive hearing devices that sit directly on the eardrum. Earlier in his career, Jeff served as Vice President, R&D/Operations at Johnson and Johnson, Vice President, Operations at Boston Scientific, and various Senior Management positions at six San Francisco Bay Area startups. He was also the recipient of the 2010 Johnson & Johnson Worldwide Supply Chain Collaboration Excellence Award where he led the integration of manufacturing operations from Acclarent into the Johnson and Johnson global supply chain. Jeff holds a B.S. in Engineering from the U.S. Military Academy at West Point and a MBA in Management from Golden Gate University. He spent six years in the US Army on active duty flying helicopters and holds an FDA commercial instrument helicopter rating.

Lisa Rosas , , , Senior Vice President, Marketing

View bioHide bio

Lisa Rosas joined Sientra in 2018. She brings over 20 years of marketing leadership in a wide range of aesthetics businesses. Prior to joining Sientra, Lisa was Vice President of Marketing at Obalon Therapeutics, which went public in 2016, and ZELTIQ Aesthetics, where she played a critical role in establishing category superiority for the CoolSculpting brand prior to the acquisition by Allergan in 2017. Lisa also held leadership positions at Medicis and Allergan previously. Lisa has been awarded a BA in communications from the University of Wisconsin and an MBA from Graziadio School of Business and Management, Pepperdine University. She has also done graduate work at the University Adolfo Ibañez in Chile as well as the University of Oxford in England.

Andy Schmidt , , , Chief Financial Officer

View bioHide bio

Andy Schmidt joined Sientra in July 2021. Andy brings to Sientra more than 20 years of financial leadership experience and has successfully directed the financial, M & A and capital market strategies of numerous publicly held companies. Most recently, he served as the CFO of Guardion Health Sciences, a Nasdaq-listed company focused on clinical nutrition, diagnostics, and medical devices. Previously, he served as the CFO of Iteris, Inc., a publicly traded global technology company. With a focus on internal and external strategic development and execution, Andy accelerated growth and achieved record stock performance. Prior, he was the CFO of publicly traded Smith Micro Software, Inc. and Genius Products, Inc. Earlier, he served in financial leadership roles with Peregrine Systems and Mad Catz Interactive. Andy received a Master of Science in Accountancy from San Diego State University and a Bachelor of Business Administration in Finance from the University of Texas, Austin, TX.

Nasdaq: SIEN

Stock Quote: NASD

$0.26 +0.00
Volume 232,791
Previous Close 0.25
Intraday High 0.27
Intraday Low 0.24
Pricing delayed 20 minutes
Price Change % Change +1.06% 52 Week High 4.43 52 Week Low 0.16 Today's Open 0.27 Dec 07, 2022 11:25 AM

Investor Contact

Sientra Investor Relations
ir@sientra.com